The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children
Official Title: Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in
Study ID: NCT06099366
Brief Summary: Aim of this study is to investigate the outcome of NGS MRD based risk stratified treatment for standard risk acute lymphoblastic leukemia in children and adolescents.
Detailed Description:
Minimum Age: 1 Year
Eligible Ages: CHILD
Sex: ALL
Healthy Volunteers: No
Asan Medical Center, Seoul, Other (Non U.s.), Korea, Republic of
Samsung Medical Center, Seoul, Other (Non U.s.), Korea, Republic of